NCT00975104View on ClinicalTrials.gov

AMG 745 in Subjects With Age-associated Muscle Loss

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

August 31, 2011

Conditions

Age-associated Muscle Loss

Interventions

DRUG

AMG 745 0.3 mg/kg

AMG 745 0.3 mg/kg IV QW

DRUG

AMG 745 1.0 mg/kg

AMG 745 1.0 mg/kg IV QW

DRUG

AMG 745 3.0 mg/kg

AMG 745 3.0 mg/kg IV QW

DRUG

Placebo

Placebo IV QW

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY